Showing 11,801 - 11,820 results of 103,572 for search '(( 5 ((we decrease) OR (a decrease)) ) OR ( 50 ((mean decrease) OR (teer decrease)) ))', query time: 1.75s Refine Results
  1. 11801
  2. 11802
  3. 11803

    SCD1 dynamics are altered in response to RSV. by Cristina Rojas (667363)

    Published 2014
    “…<b>A</b>) SCD1 gene expression levels. The results are shown as the mean of the fold change ± SD of three independent experiments. …”
  4. 11804
  5. 11805

    Effects of a single dose of ivermectin on viral and clinical outcomes in asymptomatic sars-cov-2 infected subjects: A pilot clinical trial in lebanon by Samaha, Ali A.

    Published 2021
    “…Methods: A randomized controlled trial was conducted in 100 asymptomatic Lebanese subjects that have tested positive for SARS-CoV2. …”
    Get full text
    Get full text
  6. 11806
  7. 11807

    DataSheet1_Decreasing acid value of fatty acid ethyl ester products using complex enzymes.PDF by Yuting Li (524325)

    Published 2024
    “…The optimal reaction conditions were: 1% addition of liquid lipase Eversa<sup>®</sup> Transform 2.0% and 0.8% of enzyme dry powder CALB, reaction temperature 35°C, alcohol-oil ratio 9:1 (mol/mol), 0.8 g/g of 4A-MS and reaction time 24 h. Under the optimal reaction conditions, the FAEE yield was 90.8% ± 1.5% and its acid value was decreased from 12.0 ± 0.2 mgKOH/g to 0.39 ± 0.10 mgKOH/g. …”
  8. 11808

    DataSheet_4_RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53.zip by Xiangli Liu (507857)

    Published 2022
    “…Knockdown of ALKBH5 increased global m<sup>6</sup>A level, and also increased E-cadherin, decreased stem hallmarkers, Nanog and Oct4, and inhibited stemness of CSCs. …”
  9. 11809

    DataSheet_3_RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53.zip by Xiangli Liu (507857)

    Published 2022
    “…Knockdown of ALKBH5 increased global m<sup>6</sup>A level, and also increased E-cadherin, decreased stem hallmarkers, Nanog and Oct4, and inhibited stemness of CSCs. …”
  10. 11810

    DataSheet_6_RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53.zip by Xiangli Liu (507857)

    Published 2022
    “…Knockdown of ALKBH5 increased global m<sup>6</sup>A level, and also increased E-cadherin, decreased stem hallmarkers, Nanog and Oct4, and inhibited stemness of CSCs. …”
  11. 11811

    DataSheet_1_RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53.zip by Xiangli Liu (507857)

    Published 2022
    “…Knockdown of ALKBH5 increased global m<sup>6</sup>A level, and also increased E-cadherin, decreased stem hallmarkers, Nanog and Oct4, and inhibited stemness of CSCs. …”
  12. 11812

    DataSheet_2_RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53.zip by Xiangli Liu (507857)

    Published 2022
    “…Knockdown of ALKBH5 increased global m<sup>6</sup>A level, and also increased E-cadherin, decreased stem hallmarkers, Nanog and Oct4, and inhibited stemness of CSCs. …”
  13. 11813

    DataSheet_7_RNA Demethylase ALKBH5 Prevents Lung Cancer Progression by Regulating EMT and Stemness via Regulating p53.zip by Xiangli Liu (507857)

    Published 2022
    “…Knockdown of ALKBH5 increased global m<sup>6</sup>A level, and also increased E-cadherin, decreased stem hallmarkers, Nanog and Oct4, and inhibited stemness of CSCs. …”
  14. 11814

    Inhibition of PKA by siRNA increased cell proliferation and decreases apoptosis in endothelial cells under high glucose treatment. by Zhaoyun Zhang (118032)

    Published 2012
    “…<p>Cells were transfected with siRNA and then treated with 5.6 mM glucose or 25 mM glucose for 72 hours: A: siRNA enhanced cell proliferation under high glucose conditions B: siRNA decreased apoptosis under high glucose conditions. *, p<0.05 compared with 5.6 mM condition. n = 6.…”
  15. 11815
  16. 11816
  17. 11817
  18. 11818

    Knockdown of OAMB or 5-HT<sub>1A</sub> in IPCs resulted in opposite phenotypes in a capillary feeding assay (CAFE). by Jiangnan Luo (218899)

    Published 2014
    “…<p><b>A</b> Diminishing 5-HT<sub>1A</sub> in IPCs (<i>Dilp2</i>-Gal4><i>5-HT<sub>1A</sub></i>-RNAi) significantly decreases food intake only during day 2. …”
  19. 11819

    DataSheet1_Monoclonal Antibodies Targeting IL-5 or IL-5Rα in Eosinophilic Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.DOCX by Chuchu Zhang (2562154)

    Published 2021
    “…</p><p>Results: Anti-IL-5 therapy was associated with a decrease in acute exacerbation rate (RR 0.89; 95% CI 0.84 to 0.95, I<sup>2</sup> = 0%) and the severe adverse events (RR 0.90; 95% CI 0.84 to 0.97, I<sup>2</sup> = 0%). …”
  20. 11820